News

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
Gilead Sciences has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two midstage ...
A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.
She has since received the newer, more effective shingles vaccine, as well as a pneumonia shot, an RSV vaccine to guard against respiratory syncytial virus, annual flu shots and all recommended ...
The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.